ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,971Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 6969

$654K Total Retail Price of All Prescriptions

Rank: 335 out of 6969

591 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

22% of this provider’s 591 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 17,615 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
FUROSEMIDE 1,477 1,362 1 10
SIMVASTATIN 893 785 2 1
LISINOPRIL 838 783 3 2
AMLODIPINE BESYLATE 784 737 4 4
METFORMIN HCL 647 552 5 7
BENAZEPRIL HCL 609 507 6 18
ATENOLOL 576 482 7 9
FELODIPINE ER 497 475 10 8 116
CARVEDILOL 475 437 9 25
OMEPRAZOLE 452 397 10 6
POTASSIUM CHLORIDE 412 374 11 30
HYDROCODONE-ACETAMINOPHEN 401 325 S3 12 3
HYDRALAZINE HCL 397 361 13 106
NIFEDIPINE ER 383 363 14 95
ALLOPURINOL 354 346 15 35
DIOVAN 329 306 16 26
METOPROLOL TARTRATE 327 310 17 13
CLONIDINE HCL 316 275 18 59
HYDROCHLOROTHIAZIDE 283 225 19 8
ACETAMINOPHEN-CODEINE 259 228 S3 20 73
DONEPEZIL HCL 258 233 21 32
LOSARTAN POTASSIUM 256 213 22 12
LEVOTHYROXINE SODIUM 255 235 23 5
PANTOPRAZOLE SODIUM 240 228 24 31
LOVASTATIN 235 225 25 15
GABAPENTIN 223 191 26 17
PLAVIX 176 159 27 68
NAMENDA 174 156 28 51
GLYBURIDE 173 151 R 29 54
TAMSULOSIN HCL 169 144 30 23
CLOPIDOGREL 167 147 31 48
GLIPIZIDE 166 148 32 21
PRAVASTATIN SODIUM 165 135 33 19
NIFEDIAC CC 157 140 34 248
IBUPROFEN 150 99 35 29
ATORVASTATIN CALCIUM 150 124 35 11
RANITIDINE HCL 138 122 37 46
KLOR-CON 10 131 116 38 160
RISPERIDONE 110 74 39 88
KLOR-CON 8 108 94 40 104
LACTULOSE 98 92 41 131
TRAMADOL HCL 96 73 42 27
DOXAZOSIN MESYLATE 95 89 43 74
ENALAPRIL MALEATE 94 94 44 56
ALENDRONATE SODIUM 94 94 44 14
ACTOS 93 72 46 61
DIGOXIN 92 79 47 71
KLOR-CON M20 91 91 48 201
MIRTAZAPINE 83 67 49 76
ISOSORBIDE MONONITRATE ER 81 81 50 81
ALBUTEROL SULFATE 80 80 51 123
LANTUS 80 77 51 50
WARFARIN SODIUM 78 68 53 20
DETROL LA 78 67 53 223
DILTIAZEM 24HR ER 76 76 55 183
TRIAMTERENE-HCTZ 73 65 56 58
SPIRONOLACTONE 70 68 57 102
INSULIN SYRINGE 68 61 58 60
GEMFIBROZIL 61 50 59 85
LEVEMIR 61 55 59 232
NOVOLOG 59 45 61 166
PROAIR HFA 59 50 61 33
TERAZOSIN HCL 58 58 63 49
NOVOLIN R 56 53 64 161
SERTRALINE HCL 55 31 65 38
LEVETIRACETAM 55 36 65 128
LORAZEPAM 55 55 65 186
COMBIVENT 54 52 68 170
PENTOXIFYLLINE 52 49 69 310
PHENYTOIN SODIUM EXTENDED 52 51 69 169
METOPROLOL SUCCINATE 50 50 71 22
FLUTICASONE PROPIONATE 50 49 71 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.